{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:57:59Z","timestamp":1791939479475,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.xfre.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T15:59:57Z","timestamp":1697212797000},"page":"4-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The efficacy of medical management of leiomyoma-associated heavy menstrual bleeding: a mini review"],"prefix":"10.1016","volume":"5","author":[{"given":"Mariam","family":"Barseghyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Chae-Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2023.10.003_bib1","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","article-title":"Management of symptomatic uterine leiomyomas: ACOG Practice Bulletin, Number 228","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2023.10.003_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2023.10.003_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41574-021-00629-4","article-title":"Uterine bleeding: how understanding endometrial physiology underpins menstrual health","volume":"18","author":"Jain","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.xfre.2023.10.003_bib4","first-page":"CD000400","article-title":"Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding","volume":"2019","author":"Bofill Rodriguez","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xfre.2023.10.003_bib5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2023.10.003_bib6","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.xfre.2023.10.003_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/01443615.2015.1024210","article-title":"Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: a pilot study","volume":"36","author":"Agarwal","year":"2016","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.xfre.2023.10.003_bib8","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3390\/jcm9123948","article-title":"Uterine fibroids and progestogen treatment: lack of evidence of its efficacy: a review","volume":"9","author":"Donnez","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.xfre.2023.10.003_bib9","first-page":"CD001016","article-title":"Cyclical progestogens for heavy menstrual bleeding","volume":"23","author":"Lethaby","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xfre.2023.10.003_bib10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0015-0282(03)00175-4","article-title":"Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas","volume":"79","author":"Grigorieva","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.10.003_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.xfre.2023.10.003_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/1471-0528.14383","article-title":"Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA","volume":"124","author":"Yao","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.xfre.2023.10.003_bib13","article-title":"A review of GnRH antagonists as treatment for abnormal uterine bleeding-leiomyoma (AUB-L) and their influence on the readiness of service members","author":"Wright","year":"2022","journal-title":"Mil Med"},{"key":"10.1016\/j.xfre.2023.10.003_bib14","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/AOG.0000000000002933","article-title":"Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Carr","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2023.10.003_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa2008283","article-title":"Treatment of uterine fibroid symptoms with relugolix combination therapy","volume":"384","author":"Al-Hendy","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xfre.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfre.2023.10.003_bib17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s40264-020-00975-8","article-title":"Liver injury with ulipristal acetate: exploring the underlying pharmacological basis","volume":"43","author":"Gatti","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.xfre.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/biolre\/iox094","article-title":"Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids","volume":"97","author":"Ali","year":"2017","journal-title":"Biol Reprod"},{"key":"10.1016\/j.xfre.2023.10.003_bib19","first-page":"CD010770","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","volume":"4","author":"Murji","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xfre.2023.10.003_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","article-title":"The effect of tamoxifen on the genital tract","volume":"8","author":"Polin","year":"2008","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.xfre.2023.10.003_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(01)01849-0","article-title":"Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women","volume":"76","author":"Palomba","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2023.10.003_bib22","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/jog.13105","article-title":"Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma","volume":"42","author":"Kriplani","year":"2016","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.xfre.2023.10.003_bib23","series-title":"Aromatase inhibitors for uterine fibroids","first-page":"CD009505","author":"Song","year":"2013"},{"key":"10.1016\/j.xfre.2023.10.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101159","article-title":"Effect of oral consumption of vitamin D on uterine fibroids: a randomized clinical trial","volume":"39","author":"Arjeh","year":"2020","journal-title":"Complement Ther Clin Pract"},{"key":"10.1016\/j.xfre.2023.10.003_bib25","first-page":"477","article-title":"Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study","volume":"5","author":"Roshdy","year":"2013","journal-title":"Int J Womens Health"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334123001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334123001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:32:12Z","timestamp":1719675132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334123001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2666334123001058"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2023.10.003","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of medical management of leiomyoma-associated heavy menstrual bleeding: a mini review","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}